These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Detection of the effects of the rifampin-isoniazid combination on the human liver]. Plomteux G; Heusghem C; Ferdinande R; Lecoq A; Winandy A; Parmentier JC Nouv Presse Med; 1974 Mar; 3(12):727-32. PubMed ID: 4836506 [No Abstract] [Full Text] [Related]
6. [Drug-induced hepatitis during a treatment associating isoniazid and rifampicin]. Jean R; Bonnet H; Pages P; Dumas R; Greze J Ann Pediatr (Paris); 1972 Apr; 19(4):307-11. PubMed ID: 5075678 [No Abstract] [Full Text] [Related]
7. [Hepatotoxicity of the rifampicin-isoniazid combination in children]. Bonora G; De La Pierre L; Perletti L Minerva Pediatr; 1981 Aug; 33(16):835-6. PubMed ID: 7311946 [No Abstract] [Full Text] [Related]
9. [Effect of isoniazid and rifampicin regimens on the liver of tuberculosis patients]. Pilheu JA; De Salvo MC; Barcat JA Medicina (B Aires); 1979; 39(3):298-304. PubMed ID: 514051 [No Abstract] [Full Text] [Related]
10. Toxic hepatitis with isoniazid and rifampin. A meta-analysis. Steele MA; Burk RF; DesPrez RM Chest; 1991 Feb; 99(2):465-71. PubMed ID: 1824929 [No Abstract] [Full Text] [Related]
11. Side effects of rifampicin. A clinical study. Mattson K Scand J Respir Dis Suppl; 1973; 82():1-52. PubMed ID: 4518740 [No Abstract] [Full Text] [Related]
12. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis. Grönhagen-Riska C; Hellstrom PE; Fröseth B Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874 [TBL] [Abstract][Full Text] [Related]
13. [Synergistic effect of rifampicin on hepatotoxicity of isoniazid]. Skakun NP; Shman'ko VV Antibiot Med Biotekhnol; 1985 Mar; 30(3):185-9. PubMed ID: 4015060 [TBL] [Abstract][Full Text] [Related]
14. [Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin (author's transl)]. Poupon RY; Meyniel D; Petit J; Gustot P; Darnis F Ann Med Interne (Paris); 1979; 130(6-7):371-5. PubMed ID: 496138 [TBL] [Abstract][Full Text] [Related]
16. [The optimal use of rifampicin in the polychemotherapy of pulmonary tuberculosis, with special reference to its liver-damaging potential: considerations and case studies]. Salvati F; Mugnaini L; Altieri AM; De Marinis F Clin Ter; 1979 Jan; 88(1):45-50. PubMed ID: 436377 [No Abstract] [Full Text] [Related]
17. [Fulminating hepatitis caused by administration of isoniazid and rifampicin in a patient under chronic treatment with barbiturates]. Derveaux L; Demedts M; Fevery J; Gyselen A Ned Tijdschr Geneeskd; 1980 Jun; 124(25):1008-12. PubMed ID: 7402377 [No Abstract] [Full Text] [Related]
18. [Tolerance of rifampicin in long-term treatment of patients with pulmonary tuberculosis]. Fokina LV; Vusygina RN; Antosik OD Probl Tuberk; 1976 Feb; (21):34-9. PubMed ID: 1264980 [No Abstract] [Full Text] [Related]
19. [The hepatotoxicity of rifampicin and its modification through "essential" choline phospholipids]. Kuntz HD; Rausch V; Bammel E Med Welt; 1978 Mar; 29(11):452-4. PubMed ID: 651600 [No Abstract] [Full Text] [Related]